Intensity Therapeutics Inc (NASDAQ: INTS) is -82.70% lower on its value in year-to-date trading and has touched a low of $0.28 and a high of $5.10 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The INTS stock was last observed hovering at around $0.32 in the last trading session, with the day’s loss setting it -0.02%.
Currently trading at $0.30, the stock is -27.19% and -63.95% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.72 million and changing -4.25% at the moment leaves the stock -86.79% off its SMA200. INTS registered -93.71% loss for a year compared to 6-month loss of -87.04%.
The stock witnessed a -39.09% gain in the last 1 month and extending the period to 3 months gives it a -86.41%, and is -37.06% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 32.16% over the week and 17.30% over the month.
Intensity Therapeutics Inc (INTS) has around 16 employees, a market worth around $5.60M and $0.00M in sales. Distance from 52-week low is 7.03% and -94.03% from its 52-week high. The company has generated returns on investments over the last 12 months (-3443.12%).
The EPS is expected to grow by 43.38% this year.
Intensity Therapeutics Inc (INTS) Top Institutional Holders
The shares outstanding are 15.26M, and float is at 10.02M with Short Float at 4.61%.
The top institutional shareholder in the company is SAPIENT CAPITAL LLC with over 1.01 million shares valued at $4.95 million. The investor’s holdings represent 7.3712% of the INTS Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 0.2 million shares valued at $1.0 million to account for 1.4948 of the shares outstanding. The other top investors are BROWN ADVISORY INC which holds 0.16 million shares representing 1.1488% and valued at over $0.77 million, while SIGMA PLANNING CORP holds 0.3491 of the shares totaling 47869.0 with a market value of $0.23 million.
Intensity Therapeutics Inc (INTS) Insider Activity
#####